(Exact name of registrant as specified in its charter)
Washington
000-26041
91-1714307
(State or other jurisdiction
(Commission
(IRS Employer
of incorporation)
File Number)
Identification No.)
801 5th Avenue
Seattle
,
WA
98104
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code (206) 272-5555
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common stock, no par value
FFIV
NASDAQ Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On January 15, 2023, F5, Inc. (the “Company”) director Sandra Bergeron informed the Company's Board of Directors that she would not be standing for re-nomination as a director at the next Annual Meeting of Shareholders (the “Annual Meeting”).
Ms. Bergeron has served on the Board since January 3, 2013, and has served on a number of Board committees, including as Chair of the Talent & Compensation Committee. The Board intends to appoint director Elizabeth Buse as Ms. Bergeron’s successor to chair the Talent & Compensation Committee. Ms. Bergeron’s decision was not the result of any disagreement with the Company. Ms. Bergeron will continue to serve as a director until the date of the Annual Meeting. The Board expressed its appreciation for Ms. Bergeron’s service to the Company.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
